Polycystic ovarian syndrome (PCOS) affects a significant portion of women of reproductive age, posing challenges for those seeking pregnancy. Recent research explores the efficacy of in vitro maturation (IVM) as an alternative to traditional in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) in enhancing fertility outcomes for women with PCOS.
Study Overview and Methodology
A comprehensive Cochrane review assessed four randomized controlled trials involving 810 subfertile women with PCOS. The research compared the outcomes of IVM followed by IVF or ICSI against conventional IVF or ICSI. The studies included varied in quality, with two presenting a high risk of bias and two maintaining a low risk. Data were meticulously analyzed using the Review Manager and GRADE systems to ensure robust results.
Key Findings and Implications
The analysis revealed that IVM may lead to a higher miscarriage rate compared to standard IVF, with uncertain effects on live birth and clinical pregnancy rates. However, IVM significantly reduces the risk of moderate to severe ovarian hyperstimulation syndrome (OHSS), a common complication in PCOS treatments. Additionally, there appears to be minimal difference in preterm births and congenital anomalies between the two methods.
• IVM uncertainly impacts live birth rates compared to IVF.
• Increased miscarriage rates observed with IVM.
• Significant reduction in OHSS cases using IVM.
• Preterm birth and congenital anomaly rates remain largely unaffected.
The reduction in OHSS incidents presents a notable advantage of IVM, offering a safer alternative for women prone to this condition. However, the potential for higher miscarriage rates necessitates cautious consideration when opting for IVM over conventional IVF methods.
Looking ahead, the ongoing trials are expected to provide further clarity on the long-term benefits and risks associated with IVM. Researchers emphasize the need for higher quality studies to substantiate the preliminary findings and to better understand the circumstances under which IVM can be most effectively utilized.
Advancements in assisted reproductive technologies continue to offer hope for women struggling with PCOS-related infertility. While IVM presents certain benefits, particularly in reducing OHSS, its application must be carefully weighed against the potential increase in miscarriage rates. Future research will be pivotal in defining the role of IVM in fertility treatments, ensuring that women receive the most effective and safe options available.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
